Samsung Biologics said Saturday that its product carbon footprint (PCF) system has completed third-party verification.
The company recently received a third-party verification certificate for the system from DNV, a global certification body headquartered in Norway. PCF refers to greenhouse gas emissions generated across a product’s full life cycle, from production to disposal. DNV provides verification and certification services related to quality, environment and safety based on international standards.
The verification covered biopharmaceutical manufacturing processes at the company’s first Bio Campus in Songdo, Incheon. The review found that Samsung Biologics’ in-house PCF system accurately calculates greenhouse gas emissions tied to energy and raw-material use across drug production, as well as emissions from waste and wastewater output.
The company said the result formally recognizes the system’s objectivity and reliability and shows it is carrying out activities aligned with environmental strategies sought by global customers under environmental, social and governance, or ESG, requirements.
CEO John Rim said, “This verification provides an opportunity to meet global customers’ requirements and further strengthen trust,” adding that the company will continue working to achieve its carbon-neutrality goals as an ESG leader in the pharmaceutical and biotech industry.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.